01228.HK
CANbridge Pharmaceuticals Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 1.92
−0.52%Leverage
- Debt / equity
- -0.05x
- Net debt / equity
- 0.15x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -0.20x
- Net debt / EBITDA
- 0.63x
Liquidity & coverage
- Current ratio
- 0.24x
- Quick ratio
- 0.20x
- Cash ratio
- 0.15x
- Interest coverage
- -52.52x
- EBITDA / interest
- -45.13x
- Working capital
- -HKD 402.3M
Cash & dividend
- FCF / debt
- -2.38x
- Cash flow / debt
- -2.38x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025